P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV
Clinical trial NCT04380207 · COMPLETED
Trial details
- NCT number
- NCT04380207
- Sponsor
- Qpex Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2022-08-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.